Alex Aravanis MD PhD
@Alex_Aravanis
Followers
2K
Following
505
Media
31
Statuses
169
CEO Moonwalk Biosciences
Joined May 2011
Moonwalk Biosciences to Present Data Showcasing EpiRead™ and EpiWrite™ Next-Generation Multiplex Epigenetic Engineering Platform at ASGCT 2024 https://t.co/dalOe7LTU8
businesswire.com
Moonwalk Biosciences to Present Data Showcasing EpiRead™ and EpiWrite™ Next-Generation Multiplex Epigenetic Engineering Platform at ASGCT 2024
0
0
6
#290 ‒ Liquid biopsies for early cancer detection, the role of epigenetics in aging, and the future of aging research | Alex Aravanis, M.D., Ph.D.
peterattiamd.com
“Age is your single biggest risk factor for cancer. The population over 50 is about a 10x increased risk relative to the population under 50.” —Alex Aravanis
0
2
15
Thank you to Drs. Phil Febbo @Illumina, Vivek Subbiah @SarahCannonDocs, and Prasanth Reddy @Labcorp for sharing their insights on new research supporting #CGP as a starting point in treatment for non-small cell #lungcancer. https://t.co/qqOLzV5E1c
0
2
10
Congratulations and welcome to our new pharma members! We're proud to support the whole genome sequencing and analysis of these 250k genomes.
0
0
8
Introducing DRAGEN v4.2, our most comprehensive and accurate secondary analysis tool to date. Read more about the new targeted callers, machine learning algorithm, and more: https://t.co/DMc24vavT5
2
2
32
Excited to watch Illumina Accelerator grow and expand its work under a new name, Illumina Ventures Labs. This partnership between @illumina and @illuminaventure combines the strength of both organizations to create an even bigger impact on the genomics start-up industry.
Announcing the launch of Illumina Ventures Labs! Building on the Illumina Accelerator program, it will operate & provide access to fully equipped #genomics labs in the US & UK, mentorship & seed 💵 to attract a broad range of genomics related #startups. https://t.co/OoDx6nAOWi
1
5
28
Learn more about how @illumina PrimateAI-3D algorithm uses rare variant data to shed light on common diseases such as high cholesterol and cardiovascular disease and identify those at highest risk based on polygenic risk scores. https://t.co/gzEbi0GnX1
0
7
16
The CYP21A2 gene is located in a difficult-to-sequence region and plays a role in adrenal hyperplasia. #DRAGEN v4.2 comes with a new targeted caller to genotype this gene’s and understand its impact on human health. https://t.co/YUNsdjQ6PR
#genomics
0
5
14
Learn more about the @illumina et al. #WGS study of 809 individuals from 233 different primate species and what genetic mutations tell us about our closest living relatives. https://t.co/Dkvk86MQOb
0
6
11
Broad-based genomic testing enables accurate and timely selection of targeted therapies. Let’s help make CGP the standard of care across all health centers.
The evidence is piling up, it’s time to democratize CGP. @FierceBiotech @illumina
0
0
4
Introducing PrimateAI-3D, a significant step forward in our use of deep learning to identify genetic mutations most likely to cause disease. Learn more about the groundbreaking research behind the updated algorithm, published today in @ScienceMagazine. https://t.co/OlFfHqyNfs
1
7
31
The COVID-19 state of emergency may be over, but we’ll continue to focus on NGS solutions and workflows that support global pathogen surveillance.
Dengue & Marburg & SARS, Oh My! As COVID-19 becomes an endemic public health challenge, genomic surveillance will serve as a critical component of a comprehensive global pandemic early warning system. A few thoughts about recent past, present, and future. https://t.co/J9abS4p76U
0
1
10
Thank you @BioITWorld for the article on Connected Software and new integrations with Correlation Engine. Interested in more? Join us for lunch at #BioIT23 and hear from @eurofinsviracor and @MycoTechCorp on Day 4 of the #datascience track. https://t.co/uPuCQJuEGl
"Illumina Relaunches Correlation Engine, Banking on Need for ‘Omics Informatics Tools"
0
1
8
With @illumina Correlation Engine, researchers can connect emerging omics research with established findings to push the boundaries of discovery in pharma, drug discovery, and oncology.
"Illumina Relaunches Correlation Engine, Banking on Need for ‘Omics Informatics Tools"
0
3
10
Next-gen sequencing enables researchers @AdvantaGenetics and elsewhere to test pathogens quickly and comprehensively and match them to precision therapies, helping prevent recurring or worsening infections caused by antibiotic resistance.
Precision #metagenomics could change the landscape of infectious disease diagnosis and care as we know it. @AdvantaGenetics is demonstrating the importance of using #NGS to identify harmful pathogens and stop antimicrobial resistance. More on their work: https://t.co/n9Sspde76W
0
2
10
Cases of C. auris increased dramatically during the COVID-19 pandemic. Labs such as the Nevada State Public Health Laboratory are using sequencing and wastewater surveillance to track and limit future outbreaks.
Candida auris, a deadly drug-resistant #fungus spreading in hospitals, poses a global health threat. Learn more about how public health officials are using Illumina #sequencers to help set up early warning systems to prevent and control future #outbreaks: https://t.co/62Av8hWu6G
0
2
6
The #NovaSeqX series earned an honorable mention in @FastCompany’s 2023 World Changing Ideas Awards. Congratulations to the thousands of @Illumina employees who helped bring these world-changing instruments to life and deliver them to our customers.
0
4
23
Illumina Connected Insights is helping clinical labs such as @eurofinsviracor reduce the time to actionable insights by 90%.
.@eurofinsviracor uses Illumina Connected Analytics cloud computing to analyze massive and complex data sets—reducing turnaround time and enabling greater insights. https://t.co/vOdcC5DhUx
0
0
5